Filter Results :

Your search for Diseases returned 231 reports

Sort by


Immunotherapy Drugs Market by Type of Drugs (Adult Vaccines, Checkpoint Inhibitors, Interferons Alpha), Therapy Area (Cancer, Autoimmune Diseases, Infectious Diseases), End-User (Hospitals), Region (North America, Asia-Pacific) - Global Forecast to 2021

06 Jan 2017  |  Published by:  MarketsandMarkets
The global immunotherapy drugs market is projected to reach USD 201.52 billion by 2021 from USD 108.41 billion in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021.  In this report, the immunotherapy drugs market is segmented on the basis of type of drugs, therapy area...

$ 5,650.00

Read More

Graves Diseases - Pipeline Review, H2 2016

30 Dec 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct latest Pharmaceutical and Healthcare disease pipeline guide Graves Diseases - Pipeline Review, H2 2016, provides an overview of the Graves Diseases (Hormonal Disorders) pipeline landscape.Graves' disease is an immune system disorder that results in the overproduction of ...

$ 2,000.00

Read More

In Vitro Diagnostics/IVD Market by Product (Instruments, Reagents, Software), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) - Forecast to 2021

02 Dec 2016  |  Published by:  MarketsandMarkets
The global IVD market is projected to reach USD 78.74 billion by 2021, at a CAGR of 5.5% during the forecast period of 2016 to 2021. Growth in this market is majorly driven by the increasing prevalence of diseases such as diabetes, cardiovascular diseases, and across the globe and shift in focus fro...

$ 5,650.00

Read More

Esophageal Diseases Global Clinical Trials Review, H2, 2016

30 Nov 2016  |  Published by:  GlobalData
Summary“Esophageal Diseases Global Clinical Trials Review, H2, 2016" provides an overview of Esophageal Diseases clinical trials scenario. This report provides top line data relating to the clinical trials on Esophageal Diseases. Report includes an overview of trial numbers and their average enrollm...

$ 2,500.00

Read More

Immunohistochemistry Market by Product (Antibody, Reagent, Kits, Slide Staining System, Tissue Microarray) Application (Diagnostics (Cancer, Cardiovascular, Diabetes, Autoimmune, Infectious Diseases) & Drug Testing) End User - Global Forecast to 2021

29 Nov 2016  |  Published by:  MarketsandMarkets
The immunohistochemistry (IHC) market is projected to reach USD 2.12 Billion by 2021, growing at a CAGR of 7.3% during the forecast period of 2016 to 2021. Factors such as the growing prevalence of cancer and rapidly increasing geriatric population across the globe are the primary driving the growth...

$ 5,650.00

Read More

Immunoassay Market by Product & Service (Reagents & Kits, Analyzers, Software, Services), Technique (ELISA, Rapid Test), Application (Infectious Diseases, Endocrinology, Oncology), End User (Clinical Labs, Hospitals) - Global Forecast to 2021

17 Nov 2016  |  Published by:  MarketsandMarkets
The immunoassay market is expected to reach USD 25.45 billion by 2021 from USD 17.16 billion in 2016 at a CAGR of 8.2%. The global immunoassay market is segmented based on product & service, technology, application, end user, and region. The reagents & kits segment is expected to account for...

$ 5,650.00

Read More

Inflammatory Skin Diseases-Pipeline Insights, 2016

03 Nov 2016  |  Published by:  DelveInsight
Summary Inflammatory Skin Diseases- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Inflammatory Skin Diseases. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing a...

$ 1,250.00

Read More

Liver Diseases-Pipeline Insights, 2016

03 Nov 2016  |  Published by:  DelveInsight
SUMMARY'Liver Diseases-Pipeline Insights, 2014', report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Liver Diseases. This report provides information on the the...

$ 1,250.00

Read More

Motor Neurone Diseases-Pipeline Insights, 2016

03 Nov 2016  |  Published by:  DelveInsight
Summary Motor Neurone Diseases- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Motor Neurone Diseases. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-l...

$ 1,250.00

Read More

Graves Diseases-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

03 Nov 2016  |  Published by:  DelveInsight
SummaryDelveInsight’s, Graves Diseases-API Insights, 2015,report provides Graves Diseases drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide cou...

$ 1,250.00

Read More

PEGylated Proteins Market by Consumables (PEGylation Kits, Reagents), Services, Protein Type (mAbs, Interferons), Application (Cancer Treatment, Chronic Kidney Diseases), End-User (Pharmaceutical & Biotechnology Companies) - Global Forecast to 2021

02 Nov 2016  |  Published by:  MarketsandMarkets
The global PEGylated proteins market is expected to USD 1,137.8 million by 2021 from USD 690.6 million in 2016, at a CAGR of 10.5% between 2016 and 2021. The growth of this market is mainly driven by increase in R&D spending of pharmaceutical & biotechnology companies, growth in biologics se...

$ 5,650.00

Read More

Global Orphan Diseases Partnering 2010-2016: Deal trends, players and financials

01 Nov 2016  |  Published by:  CurrentPartnering
The Global Orphan Diseases Partnering 2010-2016: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the orphan diseases partnering deals and agreements entered into by the worlds leading healthcare companies.Global Orphan Diseases Partnering 2...

$ 2,995.00

Read More

Global Infectious Diseases Partnering 2010-2016: Deal trends, players and financials

01 Nov 2016  |  Published by:  CurrentPartnering
Global Infectious Diseases Partnering 2010-2016: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the infectives partnering deals and agreements entered into by the worlds leading healthcare companies.Global Infectious Diseases Partnering 20...

$ 3,495.00

Read More

Global Sexually Transmitted Diseases Partnering 2010-2016

01 Nov 2016  |  Published by:  CurrentPartnering
Provides understanding and access to the sexually transmitted diseases partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreeme...

$ 1,495.00

Read More

Phototherapy Equipment Market by Type (Long lamp, CFL, LED, Fiber optic), Application (Skin diseases (psoriasis, vitiligo, eczema), Neonatal Jaundice), End-user, Geography (North America (USA, Canada), Europe, Asia-Pacific) - Global Forecast to 2021

21 Oct 2016  |  Published by:  MarketsandMarkets
The global phototherapy equipment market is projected to reach USD 583.4 million by 2021, growing at a CAGR of 4.5% during the forecast period of 2016 to 2021. This market is primarily driven by the huge patient population of preterm and low-weight birth babies in both developed and developing marke...

$ 5,650.00

Read More
Total 231 records.